Naveen Yalamanchi, Director, 10% Owner at ROCKET PHARMACEUTICALS, INC. (RCKT), bought 225,000 shares at $22.25 ($5.0M) on 2019-12-10, disclosed to the SEC on 2019-12-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |